Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2012
06/27/2012CN102512419A Medicinal composition and preparation method thereof
06/27/2012CN102512411A Therapy for neurodegenerative disease
06/27/2012CN102512407A Application of utilizing beta-phenylalanine compounds as aldose reductase inhibitors
06/27/2012CN102512406A Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
06/27/2012CN102512399A Long-acting naltrexone implant and preparation method thereof
06/27/2012CN102512397A Controlled release formulations and associated methods
06/27/2012CN102512395A Huperzine osmotic-pump controlled release tablet
06/27/2012CN102512378A Stable and safe oxiracetam pharmaceutical composition for injection
06/27/2012CN102512367A Formula of novel docosahexaenoic acid (DHA) fat emulsion preparation and preparation method thereof
06/27/2012CN102512363A Oxiracetam injection and preparation method thereof
06/27/2012CN102511568A Fat adjusting hypnotic health care oil
06/27/2012CN102220324B SiRNA for inhibiting gene expression of caspase-3
06/27/2012CN102188381B Preparation method of orexin-A medicament carrying liposome and medicament for treating paroxysmal sleep
06/27/2012CN102125525B Orally disintegrating tablet with rivastigmine tartrate
06/27/2012CN102125524B Piracetam orally disintegrating tablets
06/27/2012CN102119987B Traditional Chinese medicine preparation for treating epilepsy
06/27/2012CN102058849B Application of Tibetan medicine composite to preparing alcohol withdrawal medicines
06/27/2012CN102058515B Solid dispersion of 24-methylene cycloartanol ferulic acid eater and preparation thereof
06/27/2012CN102038701B Anti-depression application of albiflorin
06/27/2012CN102038660B Gastrodine solid dispersible tablet preparation and preparation method thereof
06/27/2012CN102028898B Anti-alcoholism Chinese medicinal composition
06/27/2012CN102018949B Traditional Chinese medicine composition for treating vertigo
06/27/2012CN102018904B Traditional Chinese medicine composition for treating insomnia
06/27/2012CN101972412B Composition of tall gastrodia tuber and lecithin, and preparation method thereof
06/27/2012CN101953887B Medicinal composition for preventing and treating diabetic complications and preparation method thereof
06/27/2012CN101919825B Solid effervescent mixture for the oral absorption
06/27/2012CN101912572B Multi-effect external plaster
06/27/2012CN101862422B Chinese medicinal composition for removing internal damp-heat and application thereof in relieving alcoholism and preserving health
06/27/2012CN101829168B Pharmaceutical composition for treating condyloma acuminatum and herpes, as well as preparation method thereof
06/27/2012CN101797222B Morphine sulfate sustained/controlled-release suppository and preparation method thereof
06/27/2012CN101792708B Cinnamon-longan Hakka mother wine, preparation method thereof and application as mind-tranquilizing and digestion-aiding beverage
06/27/2012CN101790522B Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists
06/27/2012CN101773493B New application of medicine compound brazilein
06/27/2012CN101756960B Duloxetine enteric-coated preparation and core material and preparation method thereof
06/27/2012CN101703596B Medicinal liquor for treating pains and other diseases caused by hyperosteogeny
06/27/2012CN101700330B Traditional Chinese medicinal capsules for treating schizophrenia
06/27/2012CN101679241B Prolinamide derivatives as NK3 antagonists
06/27/2012CN101632706B Suberect spatholobus stem extractive, preparation method, preparation and medical use thereof
06/27/2012CN101607036B Application of Chinese medicinal composition on in preparing medicament for treating depression
06/27/2012CN101600438B Therapeutic agent for pain disease
06/27/2012CN101595096B Substituted carbinol compound
06/27/2012CN101579378B Medicinal dripping pill for treating senile dementia
06/27/2012CN101564180B Walnut total nutriment and soft capsule and health products containing same
06/27/2012CN101506162B Substituted isoindoles as bace inhibitors and their use
06/27/2012CN101481421B Recombinant antigen polypeptide for treating Alzheimer's disease and polypeptide gene
06/27/2012CN101474274B Quality control method of Shensu Chinese medicine preparation
06/27/2012CN101454285B Oxadiazole derivatives as comt inhibitors
06/27/2012CN101448835B 6,7,8, 9 -tetrahydro- 5h- pyrimido [4, 5-d] azepin-4-yl] -amine derivatives as modulators of trpvl for the treatment of pain
06/27/2012CN101417123B Use of therapeutic human albumin for the preparation of a drug for the treatment of patients suffering from cognitive disorders
06/27/2012CN101417033B Traditional Chinese medicine for treating insomnia
06/27/2012CN101375927B Pharmaceutical combination for preventing birth-defect and improving memory
06/27/2012CN101374833B Novel pyrone-indole derivatives and process for their preparation
06/27/2012CN101366772B Medicament composition for preventing birth defection and improving memory
06/27/2012CN101218232B Novel oxadiazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
06/27/2012CN101166536B Method for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia
06/27/2012CN101133792B Wilding synthesized naked oat legume oat compressed granules and orange juice and method of processing the same
06/27/2012CN101133791B Wilding synthesized corn, peanut, lotus seed compressed granules and orange juice beverage and method for processing the same
06/26/2012USRE43497 Anti-MIF antibodies
06/26/2012US8207331 Benzazepine derivatives for the treatment of neurological disorders
06/26/2012US8207230 Functional role for cannabinoids in autonomic stability during sleep
06/26/2012US8207182 Substituted cyclic urea derivatives and the use thereof as vanilloid receptor 1 modulators
06/26/2012US8207177 Inhibitors of E1 activating enzymes
06/26/2012US8207168 Pyridazinone derivatives
06/26/2012US8207164 Oxazine derivatives and their use in the treatment of neurological disorders
06/26/2012US8207160 Tetrahydrobenzazepines and their use in he modulation of the dopamine D3 receptor
06/26/2012US8207159 for the treatment of disorders of the central nervous system such as cerebral, central nervous or psychiatric symptoms, defunctionalization manifestations or disorders which occur as a result of unintentional or intentional intake of psychotropic
06/26/2012US8207158 5HT2c receptor modulators
06/26/2012US8207155 Sulfonyl-azetidin-3-yl-methylamine amide analogs as GlyTl inhibitors, methods for making same, and use of same in treating psychiatric disorders
06/26/2012US8207140 Oligomeric compounds for the modulation of HIF-1α expression
06/26/2012US8206947 Human transmembrane proteins
06/26/2012US8206723 having structurally modified terminal ends which confers enhanced half-life and biological activity for use in prevention and treatment of neuromuscular and pain disorders; cosmetics
06/26/2012US8206714 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa
06/26/2012US8206699 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
06/26/2012CA2575232C 5-substituted-2-phenylamino-benzamide as mek inhibitor
06/26/2012CA2508129C Novel x-conotoxin peptides (-i)
06/26/2012CA2503211C Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent
06/26/2012CA2468082C Assay for screening candidate drugs for the treatment of inflammatory diseases
06/26/2012CA2438582C Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
06/26/2012CA2382832C Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
06/26/2012CA2328614C Matrices for drug delivery and methods for making and using the same
06/21/2012WO2012083034A1 Modulation of neurotrophic factors by omega-3 fatty acid formulations
06/21/2012WO2012082995A1 Oligomer-containing hydantoin compounds
06/21/2012WO2012082903A2 Treatment of cognitive impairment in a subject with a neurological autoimmune disease
06/21/2012WO2012081859A2 Pharmaceutical composition and functional health food for preventing and treating neurodegenerative diseases
06/21/2012WO2012081831A2 Composition comprising the extract of loranthus yadoriki sieb having monoamine oxidase-inhibiting activity
06/21/2012WO2012081713A1 Therapeutic agent for blood-brain barrier disruption syndrome
06/21/2012WO2012081692A1 Pyrazole derivative
06/21/2012WO2012081665A1 Substance capable of inhibiting glycine transporter
06/21/2012WO2012081227A1 Therapeutic agent for disc herniation
06/21/2012WO2012081017A1 Compositions and methods for treating cancer and neurodegenerative diseases
06/21/2012WO2012080952A1 Composition containing resveratrol, l-tryptophan, l-aspartic acid and vitamin b3 for use in the pharmaceutical, nutritional and cosmetic fields
06/21/2012WO2012080729A2 CASEIN KINASE 1δ (CK1δ) INHIBITORS
06/21/2012WO2012080727A2 Casein kinase 1delta (ck1delta) inhibitors
06/21/2012WO2012080554A1 Use of antioxidants for the treatment of cognitive and behavioural disorders in individuals with fragile x syndrome
06/21/2012WO2012080500A1 Serum amyloid p protein
06/21/2012WO2012080444A1 Method for suppressing an immune response
06/21/2012WO2012080408A1 Pharmaceutical composition for oral administration intended to prevent misuse
06/21/2012WO2012080399A1 Zolpidem-based orodispersible pharmaceutical tablet
06/21/2012WO2012080221A1 New compounds for the treatment of neurodegenerative diseases
06/21/2012WO2012080220A1 Novel compounds for the treatment of neurodegenerative diseases
1 ... 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 ... 1833